Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
NVIV > SEC Filings for NVIV > Form 8-K on 12-Dec-2013All Recent SEC Filings

Show all filings for INVIVO THERAPEUTICS HOLDINGS CORP.

Form 8-K for INVIVO THERAPEUTICS HOLDINGS CORP.


12-Dec-2013

Change in Directors or Principal Officers


Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 8, 2013, Gregory D. Perry, Interim Chief Financial Officer of InVivo Therapeutics Holdings Corp. (the "Company"), whose term was set to expire on December 16, 2013, notified the Company that he would be pursuing another opportunity.

On December 11, 2013, the Company and Mr. Perry entered into an amendment to Mr. Perry's employment agreement to extend his term through December 30, 2013. During this extension, Mr. Perry will commit four days per week to the Company.

The Board of Directors is continuing its search for a permanent Chief Financial Officer.


  Add NVIV to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for NVIV - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.